The PI3K/AKT Signaling Pathway Controls the Quiescence of the Low-Rhodamine123-Retention Cell Compartment Enriched for Melanoma Stem Cell Activity
-
- Yasmine Touil
- Inserm U837 Jean-Pierre Aubert Research Center, Institut pour la Recherche sur le Cancer de Lille (IRCL), 1 Place de Verdun, 59045 Lille, France
-
- Thomas Zuliani
- Inserm U837 Jean-Pierre Aubert Research Center, Institut pour la Recherche sur le Cancer de Lille (IRCL), 1 Place de Verdun, 59045 Lille, France
-
- Isabelle Wolowczuk
- Laboratory of Neuroimmunoendocrinology, Institut Pasteur de Lille, BP447, Lille 59019, France
-
- Klaudia Kuranda
- Inserm U837 Jean-Pierre Aubert Research Center, Institut pour la Recherche sur le Cancer de Lille (IRCL), 1 Place de Verdun, 59045 Lille, France
-
- Jirina Prochazkova
- Department of Animal Physiology and Immunology, Faculty of Science, Masaryk University, Brno, Czech Republic
-
- Joris Andrieux
- Institut de Génétique Médicale, Hôpital Jeanne de Flandre, CHRU de Lille, 59019 Lille, France
-
- Helene Le Roy
- Inserm U837 Jean-Pierre Aubert Research Center, Institut pour la Recherche sur le Cancer de Lille (IRCL), 1 Place de Verdun, 59045 Lille, France
-
- Laurent Mortier
- Service de Dermatologie, Centre Hospitalier et Universitaire de Lille, 59045 Lille, France
-
- Jerome Vandomme
- Inserm U837 Jean-Pierre Aubert Research Center, Institut pour la Recherche sur le Cancer de Lille (IRCL), 1 Place de Verdun, 59045 Lille, France
-
- Nathalie Jouy
- BiCell-IFR114, IRCL, 1 Place de Verdun, 59045 Lille, France
-
- Bernadette Masselot
- Inserm U837 Jean-Pierre Aubert Research Center, Institut pour la Recherche sur le Cancer de Lille (IRCL), 1 Place de Verdun, 59045 Lille, France
-
- Pascaline Ségard
- Inserm U837 Jean-Pierre Aubert Research Center, Institut pour la Recherche sur le Cancer de Lille (IRCL), 1 Place de Verdun, 59045 Lille, France
-
- Bruno Quesnel
- Inserm U837 Jean-Pierre Aubert Research Center, Institut pour la Recherche sur le Cancer de Lille (IRCL), 1 Place de Verdun, 59045 Lille, France
-
- Pierre Formstecher
- Inserm U837 Jean-Pierre Aubert Research Center, Institut pour la Recherche sur le Cancer de Lille (IRCL), 1 Place de Verdun, 59045 Lille, France
-
- Renata Polakowska
- Inserm U837 Jean-Pierre Aubert Research Center, Institut pour la Recherche sur le Cancer de Lille (IRCL), 1 Place de Verdun, 59045 Lille, France
抄録
<jats:title>Abstract</jats:title> <jats:p>Melanoma is one of the most aggressive and extremely resistant to conventional therapies neoplasms. Recently, cellular resistance was linked to the cancer stem cell phenotype, still controversial and not well-defined. In this study, we used a Rhodamine 123 (Rh123) exclusion assay to functionally identify stem-like cells in metastatic human melanomas and melanoma cell lines. We demonstrate that a small subset of Rh123-low-retention (Rh123low) cells is enriched for stem cell-like activities, including the ability to self-renew and produce nonstem Rh123high progeny and to form melanospheres, recapitulating the phenotypic profile of the parental tumor. Rh123low cells are relatively quiescent and chemoresistant. At the molecular level, we show that melanoma Rh123low cells overexpress HIF1α, pluripotency factor OCT4, and the ABCB5 marker of melanoma stem cells and downregulate the expression of Cyclin D1 and CDK4. Interestingly, a short treatment with LY294002, an inhibitor of the PI3K/AKT pathway, specifically reverts a subset of Rh123high cells to the Rh123low phenotype, whereas treatment with inhibitors of mammalian target of rapamycin, phosphatase and tensin homolog or mitogen-activated protein kinase signaling does not. This phenotypic switching was associated with reduced levels of the HIF1α transcript and an increase in the level of phosphorylated nuclear FOXO3a preferentially in Rh123low cells. Moreover, the Rh123low cells became less quiescent and displayed a significant increase in their melanosphere-forming ability. All the above indicates that the Rh123low melanoma stem cell pool is composed of cycling and quiescent cells and that the PI3K/AKT signaling while maintaining the quiescence of Rh123low G0 cells promotes the exit of cycling cells from the stem cell compartment.</jats:p>
収録刊行物
-
- Stem Cells
-
Stem Cells 31 (4), 641-651, 2013-03-24
Oxford University Press (OUP)